PCV13

pneumococcal conjugate vaccine 13-valent · Beijing Minhai Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PCV13, covering 2022-10-12 to 2024-01-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years [Phase 4]

See pricing